Bionano Genomics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BNGO, updated each market day.
BNGO AI Sentiment
AI sees no strong directional signal for Bionano Genomics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Bionano Genomics, Inc. Common Stock
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Sector
Exchange
Market Cap
$12,866,720
Cap Tier
Employees
97
Headquarters
SAN DIEGO, CA
Listed Since
Aug. 1, 2018
Website
BNGO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BNGO Volatility
Bionano Genomics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
